Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers
2013 Standout
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
2004
The Significance of c-erb B-2 and p53 Immunoreactivity in Patients with Adenocarcinoma of the Esophagus
1995
Metastatic Basal Cell Carcinoma: Complete Response to Chemotherapy and Associated Pure Red Cell Aplasia
2006
Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma
1992
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Combined radiofrequency ablation and high–dose rate brachytherapy for early-stage non–small-cell lung cancer
2010
Prognostic Factors in Non-small Cell Lung Cancer
2002
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer
1995
Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma
1993
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma
1997
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
1990
National Cancer Data Base report on esophageal carcinoma
1996
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats
2002
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Histologic Considerations for Individualized Systemic Therapy Approaches for the Management of Non-small Cell Lung Cancer
2009
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995
Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies
2008
Lung Cancer
2008 Standout
Head and neck cancer
2008 Standout
Gestational trophoblastic disease
2010 Standout
Significance of Nuclear Accumulation of Foxo3a in Esophageal Squamous Cell Carcinoma
2008
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
1991
Esophageal Cancer
2003 Standout
Antiproliferative and Apoptotic Effects of Iron Chelators on Human Cervical Carcinoma Cells
2002
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
1992 Standout
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
1994 Standout
Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma
2001
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.
1997
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
2007
Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix
1997
Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
1990
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization
2007
Oesophageal carcinoma
2013 Standout
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
1995 Standout
Mortality risk score for Klebsiella pneumoniae bacteraemia
2014
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
2007
Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer
2013
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Adenocarcinoma of the esophagus and esophguo-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment
1990
Head and Neck Cancer
1993 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
1994
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Gefitinib (ZD1839, Iressa®) in non‐small‐cell lung cancer: a review of clinical trials from a daily practice perspective
2005
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Cervical cancer
2019 Standout
Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices
2010
Protective effect of procaine hydrochloride on cisplatin-induced alterations in rat kidney
2002
Biological effects of essential oils – A review
2007 Standout
Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study
2005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention
1997
Cutaneous Adverse Effects With HER1/EGFR-Targeted Agents: Is There a Silver Lining?
2005
Management of Cancer in the Older Person: A Practical Approach
2000
EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment
2005
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non–Small-Cell Lung Cancer
2005
Chemotherapy of advanced non-small cell lung cancer
1999
Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study
2004
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy
1990
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer
2007
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma
1985
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
2005
Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies
2007
[ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
2007
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
2015
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
1999
Works of Ralph Vance being referenced
Chemotherapy in Advanced Ovarian Carcinoma: Current Standards of Care Based on Randomized Trials
1994
The Role of Chemotherapy in the Management of Celomic Epithelial Carcinoma of the Ovary
1997
Second‐line chemotherapy for recurrent carcinoma of the ovary
1993
Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma
1991
Chemotherapy for advanced or recurrent gynecologic cancer
1987
Basal Cell Carcinoma With Lung Metastasis Diagnosed by Fine-Needle Aspiration Biopsy
1999
Lung Cancer and Radiofrequency Ablation
2006
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study
2005
Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126
2004
Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126
2006
Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.
1995
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study.
1986
Limitations of High Dose Intra-arterial 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) Chemotherapy for Malignant Gliomas
1982
The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
1996
Carcinoma of the uterine cervix: current status and future directions.
1994
Nutrition, Cancer, and Aging: An Annotated Review
1986
The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
1995
The role of paclitaxel in the management of patients with carcinoma of the cervix.
1997
Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).
1987
Acute leukemia and infections: Perspectives from a general hospital
1983
Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma
1981